Why the study?
Does co-exposure to hydrogenated nanodiamonds and irradiation increase cytotoxicity in radioresistant cancer cells?
Does co-exposure to hydrogenated nanodiamonds and irradiation increase cytotoxicity in radioresistant cancer cells?
Hydrogenated nanodiamonds can sensitize radioresistant cancer cells to radiation therapy by inducing DNA damage and senescence.
H-NDs may sensitize radioresistant cells to radiation; leaves open clinical translation from animal data.
Hydrogenated nanodiamonds (H-NDs) exhibit a negative electron affinity that confers a high reactivity with oxygen species and a positive charge in aqueous solutions. It allows electron emission from H-NDs following irradiation by photons and in consequence may enhance the effects of radiation on cancer cells. By using three human radioresistant cancer cell lines, we showed a potentialization of cytotoxicity after a co-exposure to H-NDs and irradiation; an event occurring through the induction of DNA damage and reactive oxygen species. This occurred together with a decrease in cell impedance, the activation of G1/S, an unlocking of G2 cell cycle check-points and early low cell death rate. At later stage of exposure, persistent increases in heterochromatinization, large γ-H2AX foci and β-galactosidase activity were detected providing evidence of cells' entrance into senescence. Similar potentialization was observed with neocarzinostatin (NCS), a radiomimetic drug. This original finding underlines a wide clinical potential of H-NDs to intensify radiation effects on radio-resistant cancer cells.
No takes yet. Share an insight, caveat, or question.
Grall et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: